In an article for U.S. News & World Report about innovations for seniors, Teresa Mears reports that MIT researchers are developing a shirt that can sense a heart attack and administer CPR. While “such a shirt is [probably] 15 years away, shirts with sensors are already on the market, used primarily by athletes,” writes Mears.
Emma Woollacott reports for Forbes on Vuvuzela, a text-messaging system that MIT researchers developed to encrypt the metadata and content of messages. “Vuvuzela uses multiple servers instead of one, to give each message multiple layers of encryption,” writes Woollacott.
In this video, CBS News correspondent Don Dahler speaks with Prof. Dina Katabi about her group’s work developing wireless technology that can track a person’s motion through walls. Katabi and her colleagues demonstrated how the system also detects a person’s elevation and could be used to help protect seniors at risk of falling.
MIT researchers have developed a new bandage that can detect infection and automatically release medication, reports Jordan Graham for The Boston Herald. “We are trying to design long-term, high-efficiency interfaces between the body and electronics,” explains Prof. Xunahe Zhao.
In an article for Optics.org, Matthew Peach writes that MIT researchers have developed a technique that exploits the polarization of light to improve the quality of 3-D imaging. The technique “could lead to high-quality 3-D cameras integrated into cellphones, and perhaps to the ability to photograph an object and then use a 3-D printer to produce a replica.”
Boston Globe reporter Kevin Hartnett speaks with MIT conservator Jana Dambrogio about a collection of letters from 1689-1707. “It’s not like when you fold a letter three times and stick it in an envelope,” says Dambrogio. “When these things are folded, some areas of the rectangle could have 8 or 10 folds in one spot.”
MIT was named one of the top 25 employers in Forbes and Statista.com’s list of America’s best large employers, reports Justine Hofherr for Boston.com.
NBC News reporter Maggie Fox writes that MIT researchers have developed a stretchy, wet bandage that can deliver medications. The device could “carry a thermometer to continuously measure skin temperature, or tiny devices to keep an eye on blood sugar levels for someone with diabetes.”
Anne Fisher reports for Fortune on a new paper co-authored by Senior Lecturer Don Sull that found that a large number of senior managers at major corporations do not know their companies’ priorities. “Among senior managers directly involved in setting their companies’ objectives, only about half could identify them,” writes Fisher.
“MIT professor emerita Joan Jonas, who represented the United States at the Venice Biennale, has been named the next visual arts mentor for the Rolex Mentor and Protégé Arts Initiative,” writes Meredith Goldstein for The Boston Globe. Jonas was named to the initiative along with five other artists.
Chris Sweeney reports for Boston Magazine that Prof. Cynthia Breazeal’s lab is participating in a new National Institutes of Health program aimed at examining how social robots can improve health and wellness. “The NIH wants to see if Breazeal’s creations can help ‘inspire curiosity’ and teach ‘the importance of hard work and determination’ to school-aged children,” writes Sweeney.
Los Angeles Times reporter Evan Halper speaks with MIT Corporation member and alumna Leslie Dewan, co-founder of Transatomic Power, about nuclear energy and climate change. “I became a nuclear engineer because I am an environmentalist,” said Dewan. “The world needs a cheap source of carbon-free power.”
Natalie Handy of The Cambridge Chronicle writes about the MIT Museum’s Chain Reaction event, during which teams of people came together to build a mega machine. “Getting people involved, getting people excited, and dreaming and thinking about what they can make is what it’s all about,” said Jennifer Novotney of the MIT Museum.
BBC News reporter Michelle Roberts writes that MIT researchers have fine-tuned the CRISPR-Cas9 genome editing system to make it safer and more accurate. This development is "vital if it [CRISPR] is to be used in humans to cure inherited diseases or inborn errors,” explains Roberts.
In an article for the Financial Times, Martin Sandbu argues that renewable energy should be seen as an opportunity for investment, highlighting an MIT report on renewable energy costs. The report documents the “extraordinary fall in renewable electricity generation costs and the good reason to expect them to continue to fall.”